Ubs Group Ag Dermata Therapeutics Inc Wt Ex Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Dermata Therapeutics Inc Wt Ex stock. As of the latest transaction made, Ubs Group Ag holds 2,617 shares of DRMAW stock, worth $52. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,617
Previous 4,142
36.82%
Holding current value
$52
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DRMAW
# of Institutions
5Shares Held
203KCall Options Held
0Put Options Held
0-
Empery Asset Management, LP New York, NY175KShares$3,5000.1% of portfolio
-
Two Sigma Securities, LLC New York, NY13.2KShares$2640.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY12KShares$2400.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About DERMATA THERAPEUTICS INC WT EX
- Ticker DRMAW
- Sector Healthcare
- Industry Biotechnology